Terms: = Uterine cancer AND NUTM2A, ENSG00000184923, Q5VT03, Q8IVF1, KIAA2020, 728118, FAM22A AND Prognosis
5 results:
1. High-grade endometrial stromal sarcoma displaying immunohistochemical expression of BCOR-A report of two cases of a novel tumor entity.
Wagh V; Menon S; Maheshwari A; Gupta S; Deodhar KK; Rekhi B
Indian J Pathol Microbiol; 2023; 66(4):829-833. PubMed ID: 38084541
[TBL] [Abstract] [Full Text] [Related]
2. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
[TBL] [Abstract] [Full Text] [Related]
3. Breast metastasis in high-grade endometrial stromal sarcoma (HG-ESS) with BCOR rearrangement: a case report of a novel metastatic site.
Fong A; Offman S
Diagn Pathol; 2023 Mar; 18(1):34. PubMed ID: 36864468
[TBL] [Abstract] [Full Text] [Related]
4. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
[TBL] [Abstract] [Full Text] [Related]
5. uterine sarcoma Part II-uterine endometrial stromal sarcoma: The TAG systematic review.
Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
[TBL] [Abstract] [Full Text] [Related]